Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gala Health vs Luvo Health

Gala Health
Graded #17

Higher grade

vs+21.900000000000006
Luvo Health
Graded #305

Lower grade

The verdict

Gala Health takes it — 82.9/100 to 61/100.

Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A compounded tirzepatide and semaglutide program for women that reaches all 50 states and keeps a brand-name Ozempic path open — but its $179 and $149 headline rates are yearly-subscription prices, not monthly ones.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGala Health +46
84
38
Dose & formulationLuvo Health +5
83
88
Clinical oversightGala Health +17
85
68
Labs & monitoringGala Health +31
83
52
FulfillmentGala Health +14
88
74
Contract termsGala Health +21
66
45
Gala Health · left barLuvo Health · right bar

The numbers

MetricGala HealthLuvo Health
WeighScore82.9/10061/100
GradeB−C
Scorecard rank#17#305
SemaglutideNot disclosed$249/mo (compounded)
Tirzepatide$179/mo (yearly subscription)$339/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Gala Health

Graded #17 · B−

Strengths

  • Low compounded entry if you prepay the year — $179/mo tirzepatide and $149/mo microdose on the yearly subscription, $199/mo on a 3-month plan
  • Prices are published openly rather than quiz-gated, with all doses included at the one rate
  • All 50 states and LegitScript-verified, with a brand-name Ozempic path kept open ($1,299)
  • HRT and menopause care available alongside GLP-1

Where it loses points

  • No month-to-month price is published anywhere — the $179 tirzepatide and $149 microdose rates are both yearly subscriptions, and the shortest term Gala names is a 3-month plan at $199/mo
  • Compounded formulations are not FDA-approved
  • Brand-name Ozempic is priced steeply at $1,299
  • No oral or sublingual route offered yet — injection only
  • Newer operator (Gala GLP-1 by AI Coaching Inc) with no named clinicians and no named dispensing pharmacy
Luvo Health

Graded #305 · C

Strengths

  • Full price list published openly, by medication and by commitment length, with no intake required
  • Offers both compounded and brand-name Ozempic and Zepbound in one place
  • Oral semaglutide tablets available as well as injections
  • Full refund if a provider disqualifies you before medication is ordered
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
  • You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
  • Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
  • Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
  • Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard